1,560
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

miR-152-3p aggravates vascular endothelial cell dysfunction by targeting DEAD-box helicase 6 (DDX6) under hypoxia

, , , , , , , , & ORCID Icon show all
Pages 4899-4910 | Received 12 May 2021, Accepted 20 Jul 2021, Published online: 10 Aug 2021

References

  • Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the global burden of disease study 2010. Lancet. 2014 Jan 18;383(9913):245–255.
  • Zhong C, Yin C, Niu G, et al. MicroRNA miR-497 is closely associated with poor prognosis in patients with cerebral ischemic stroke. Bioengineered. 2021 Dec;12(1):2851–2862.
  • Chauhan G, Debette S. Genetic risk factors for ischemic and hemorrhagic stroke. Curr Cardiol Rep. 2016 Dec;18(12):124.
  • GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459–1544.
  • El Amki M, Wegener S. Improving cerebral blood flow after arterial recanalization: a novel therapeutic strategy in stroke. Int J Mol Sci. 2017 Dec 9;18:12.
  • Kong Q, Hao Y, Li X, et al. HDAC4 in ischemic stroke: mechanisms and therapeutic potential. Clin Epigenetics. 2018 Sep 12;10(1):117.
  • Hatakeyama M, Ninomiya I, Kanazawa M. Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen Res. 2020 Jan;15(1):16–19.
  • Krupinski J, Kaluza J, Kumar P, et al. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 1994 Sep;25(9):1794–1798.
  • Zhang B, Li J. Phoenixin-14 protects human brain vascular endothelial cells against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced inflammation and permeability. Arch Biochem Biophys. 2020 Mar 30;682:108275.
  • Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016 Jan-Mar;4(1):e1138017.
  • Liu W, Wang P, Shang C, et al. Endophilin-1 regulates blood-brain barrier permeability by controlling ZO-1 and occludin expression via the EGFR-ERK1/2 pathway. Brain Res. 2014 Jul 21;1573:17–26.
  • Yuan S, Liu KJ, Qi Z. Occludin regulation of blood-brain barrier and potential therapeutic target in ischemic stroke. Brain Circ. 2020 Jul-Sep;6(3):152–162.
  • Mellis D, Caporali A. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target. Biochem Soc Trans. 2018 Feb 19;46(1):11–21.
  • Nong A, Li Q, Huang Z, et al. MicroRNA miR-126 attenuates brain injury in septic rats via NF-κB signaling pathway. Bioengineered. 2021 Dec 12;12(1):2639–2648.
  • Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79(1):351–379.
  • Gong M, Yu B, Wang J, et al. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget. 2017 Jul 11;8(28):45200–45212.
  • Arderiu G, Peña E, Aledo R, et al. MicroRNA-145 regulates the differentiation of adipose stem cells toward microvascular endothelial cells and promotes angiogenesis. Circ Res. 2019 Jun 21;125(1):74–89.
  • Shi Y, Xu X, Luan P, et al. miR‑124‑3p regulates angiogenesis in peripheral arterial disease by targeting STAT3. Mol Med Rep. 2020 Dec;22(6):4890–4898.
  • Zhang T, Tian C, Wu J, et al. MicroRNA-182 exacerbates blood-brain barrier (BBB) disruption by downregulating the mTOR/FOXO1 pathway in cerebral ischemia. Faseb J. 2020 Oct;34(10):13762–13775.
  • Xie K, Cai Y, Yang P, et al. Upregulating microRNA-874-3p inhibits CXCL12 expression to promote angiogenesis and suppress inflammatory response in ischemic stroke. Am J Physiol Cell Physiol. 2020 Sep 1;319(3):C579–c588.
  • Yang Y, Fang X, Yang R, et al. MiR-152 regulates apoptosis and triglyceride production in MECs via Targeting ACAA2 and HSD17B12 Genes. Sci Rep. 2018 Jan 11;8(1):417.
  • Miao W, Bao TH, Han JH, et al. Neuroprotection induced by post-conditioning following ischemia/reperfusion in mice is associated with altered microRNA expression. Mol Med Rep. 2016 Sep;14(3):2582–2588.
  • Song P, Sun H, Chen H, et al. Decreased serum exosomal miR-152-3p contributes to the progression of acute ischemic stroke. Clin Lab. 2020 Aug 1;66(8/2020):8.
  • Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014 Jan;42(D1):D92–7.
  • De Vries S, Naarmann-de Vries IS, Urlaub H, et al. Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia. J Biol Chem. 2013 Feb 22;288(8):5815–5827.
  • Lee YC, Chang YC, Wu CC, et al. Hypoxia-preconditioned human umbilical vein endothelial cells protect against neurovascular damage after hypoxic ischemia in neonatal brain. Mol Neurobiol. 2018 Oct;55(10):7743–7757.
  • Dalby B, Cates S, Harris A, et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 2004 Jun;33(2):95–103.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402–408.
  • Hu C, Bai X, Liu C, et al. Long noncoding RNA XIST participates hypoxia-induced angiogenesis in human brain microvascular endothelial cells through regulating miR-485/SOX7 axis. Am J Transl Res. 2019;11(10):6487–6497.
  • Duan MX, Zhou H, Wu QQ, et al. Andrographolide protects against HG-induced inflammation, apoptosis, migration, and impairment of angiogenesis via PI3K/AKT-eNOS signalling in HUVECs. Mediators Inflamm. 2019;2019:6168340.
  • Zheng J, Zhuo YY, Zhang C, et al. LncRNA TTTY15 regulates hypoxia-induced vascular endothelial cell injury via targeting miR-186-5p in cardiovascular disease. Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3293–3301.
  • Bezzaouha A, Bouamra A, Ammimer A, et al. Non-parametric tests on SPSS to compare two or more means on matched samples. Tunis Med. 2020 Dec;98(12):932–941.
  • Kuriakose D, Pathophysiology XZ. Treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020 Oct 15;21(20):20.
  • Yang C, Hawkins KE, Doré S, et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C135–c153.
  • Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008 Nov;32(2):200–219.
  • Mirzaei H, Momeni F, Saadatpour L, et al. MicroRNA: relevance to stroke diagnosis, prognosis, and therapy. J Cell Physiol. 2018 Feb;233(2):856–865.
  • Venkat P, Cui C, Chopp M, et al. MiR-126 mediates brain endothelial cell exosome treatment-induced neurorestorative effects after stroke in type 2 diabetes mellitus mice. Stroke. 2019 Oct;50(10):2865–2874.
  • Wang J, Chen S, Zhang W, et al. Exosomes from miRNA-126-modified endothelial progenitor cells alleviate brain injury and promote functional recovery after stroke. CNS Neurosci Ther. 2020 Dec;26(12):1255–1265.
  • Bernstein DL, Zuluaga-Ramirez V, Gajghate S, et al. miR-98 reduces endothelial dysfunction by protecting blood-brain barrier (BBB) and improves neurological outcomes in mouse ischemia/reperfusion stroke model. J Cereb Blood Flow Metab. 2020 Oct;40(10):1953–1965.
  • Desjarlais M, Rivera JC, Lahaie I, et al. MicroRNA expression profile in retina and choroid in oxygen-induced retinopathy model. PLoS One. 2019;14(6):e0218282.
  • Roslavtceva VV, Salmina AB, Prokopenko SV, et al. [The role of vascular endothelial growth factor in the regulation of development and functioning of the brain: new target molecules for pharmacotherapy]. Biomed Khim. 2016 Mar-Apr;62(2):124–133.
  • Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci. 2015 Jul;1347(1):45–51.
  • Sun B, Liu Y, Huang W, et al. Functional identification of a rare vascular endothelial growth factor a (VEGFA) variant associating with the nonsyndromic cleft lip with/without cleft palate. Bioengineered. 2021 Dec;12(1):1471–1483.
  • Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004 Jun;16(1):1–13.
  • Nian K, Harding IC, Herman IM, et al. Blood-brain barrier damage in ischemic stroke and its regulation by endothelial mechanotransduction. Front Physiol. 2020;11:605398.
  • Reinhold AK, Rittner HL. Barrier function in the peripheral and central nervous system - a review. Pflugers Arch. 2017 Jan;469(1):123–134.
  • Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009 Jan;19(1):92–105.
  • Wang R, Bai Z, Wen X, et al. MiR-152-3p regulates cell proliferation, invasion and extracellular matrix expression through by targeting FOXF1 in keloid fibroblasts. Life Sci. 2019 Oct 1;234:116779.
  • Łuczkowska K, Rogińska D, Ulańczyk Z, et al. Effect of bortezomib on global gene expression in PC12-derived nerve cells. Int J Mol Sci. 2020 Jan 23;21(3):3.
  • Marcon BH, Rebelatto CK, Cofré AR, et al. DDX6 helicase behavior and protein partners in human adipose tissue-derived stem cells during early adipogenesis and osteogenesis. Int J Mol Sci. 2020 Apr 9;21(7):7.
  • Nicklas S, Okawa S, Hillje AL, et al. The RNA helicase DDX6 regulates cell-fate specification in neural stem cells via miRNAs. Nucleic Acids Res. 2015 Mar 11;43(5):2865–2874.
  • Chauderlier A, Gilles M, Spolcova A, et al. Tau/DDX6 interaction increases microRNA activity. Biochim Biophys Acta Gene Regul Mech. 2018 Aug;1861(8):762–772.
  • Karaman S, Leppänen VM, Alitalo K. Vascular endothelial growth factor signaling in development and disease. Development. 2018 Jul 20;145(14):14.
  • Saito K, Kondo E, MicroRNA MM. 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Res. 2011 Aug;39(14):6086–6099.